Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ C4655898!4655898!26634180     free     free     free       Innov+Clin+Neurosci ä ; 12 (9-10): 33-6 Nephropedia Template TP {{tp|p=26634180|t=ä. Aripiprazole for Treatment of Apathy |pdf=|usr=}}{{26634180}} gab.com Text Aripiprazole for Treatment of Apathy JO: Innov Clin Neurosci http://www.kidney.de/pget.php?&tw=1&pmid=26634180 #FOAvip Objective: The objective of this article is to present a case of improved outcome of apathy syndrome with aripiprazole.Case summary: A 42-year-old man with depression and seizure disorder had significant apathy that did not respond to carbamazepine, sertraline, and topiramate. Apathy was assessed using Apathy Evaluation Scale. Discontinuation of carbamazepine did not alleviate apathy. Aripiprazole, a novel antipsychotic with partial agonistic activity at dopamine D2 receptors, was introduced and the dose adjusted to 15mg a day. The patient showed significant improvement in apathy after six weeks of therapy with aripiprazole.Discussion: Depression is often mistaken for apathy, which is different in symptoms, presentation, and treatment options. Selective serotonin reuptake inhibitors are known to cause or increase symptoms of apathy in some patients. Recent evidence suggests that dopamine receptor agonists can be helpful in treatment of apathy. Apathy significantly improved in this patient after initiation of aripiprazole.Conclusion: Aripiprazole may be useful for treatment of apathy syndrome. Its role in treatment of apathy requires further investigation in clinical trials. Twit Text FOAVip Aripiprazole for Treatment of Apathy ????Innov Clin Neurosci http://www.kidney.de/pget.php?&tw=1&pmid=26634180 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26634180 #FOAvip English Wikipedia <ref>{{Cite pmid|26634180}}</ref> Aripiprazole for Treatment of Apathy #MMPMID26634180 Monga V; Padala PR Innov Clin Neurosci ä[]; 12 (9-10): 33-6 PMID26634180show ga Objective: The objective of this article is to present a case of improved outcome of apathy syndrome with aripiprazole.Case summary: A 42-year-old man with depression and seizure disorder had significant apathy that did not respond to carbamazepine, sertraline, and topiramate. Apathy was assessed using Apathy Evaluation Scale. Discontinuation of carbamazepine did not alleviate apathy. Aripiprazole, a novel antipsychotic with partial agonistic activity at dopamine D2 receptors, was introduced and the dose adjusted to 15mg a day. The patient showed significant improvement in apathy after six weeks of therapy with aripiprazole.Discussion: Depression is often mistaken for apathy, which is different in symptoms, presentation, and treatment options. Selective serotonin reuptake inhibitors are known to cause or increase symptoms of apathy in some patients. Recent evidence suggests that dopamine receptor agonists can be helpful in treatment of apathy. Apathy significantly improved in this patient after initiation of aripiprazole.Conclusion: Aripiprazole may be useful for treatment of apathy syndrome. Its role in treatment of apathy requires further investigation in clinical trials. äAripiprazole for Treatment of Apathy (epmc).pdf DeepDyve Pubget Overpricing